Compare COPD inhalers and insulin pens with new MIMS tables

Quick-reference comparison charts for COPD combination inhalers and insulin delivery devices are now available online and in the latest print edition of MIMS.

The new tables are included in the March print issue of MIMS and updated constantly online.
The new tables are included in the March print issue of MIMS and updated constantly online.

MIMS has introduced two new resources for prescribers treating patients with COPD or diabetes.

COPD inhalers

A new table of COPD combination inhalers provides essential information for healthcare professionals prescribing a dual or triple combination device. 

The table is designed to help prescribers either stepping up treatment or starting a combination inhaler in patients already adequately controlled on separate devices, as well as those looking for an alternative combination device where the existing choice is unsuitable.

Listing all available combination LABA/LAMA, LABA/corticosteroid and LABA/corticosteroid/LAMA devices, the table summarises:

  • Metered/pre-dispensed and delivered doses
  • Inhaler type (breath-actuated or pressurised metered-dose)
  • Dose counter and confirmation features
  • Compatible spacers

Insulin pens

In addition to the new inhalers table, MIMS users can find a new table summarising the key features of pre-filled and reusable insulin pens.

The table lists the dose ranges and increments, compatible needles, and strengths (for pre-filled pens) or compatible cartridges (for reusable pens), among other features. Pre-filled pens are classified by insulin type (very rapidly acting, intermediate acting, long acting or biphasic).

In both tables, drug names link through to the full MIMS entries for more detailed prescribing information on each branded or generic product.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Check on the latest drug supply issues with MIMS' shortages...

Novel MS drug gains NICE approval

Novel MS drug gains NICE approval

New NICE guidance recommends ocrelizumab (Ocrevus)...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

NICE recommends new triple therapy option for diabetes

NICE recommends new triple therapy option for diabetes

Ertugliflozin (Steglatro) can now be prescribed routinely...